{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:39:45Z","timestamp":1791578385159,"version":"4.3.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Curcumin, the active ingredient in turmeric, is employed by numerous cancer patients to support conventional cancer therapy. This systematic review aims to summarize the existing clinical evidence and to provide an overview of the potential benefits and risks associated with curcumin supplementation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In January 2024, we conducted a systematic search of five electronic databases (Embase, Cochrane, PsycInfo, CINAHL, and Medline) using a complex search strategy. We included randomized controlled trials on the use, effectiveness, and potential harm of additional curcumin therapy in adult patients under cancer treatment. The risk of bias was assessed using Cochrane revised Risk of Bias Tool 2.0.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This systematic review included 34 randomized controlled trials involving 2580 patients out of 11143 search results. Included patients were primarily diagnosed with head and neck cancer, followed by breast, prostate, and colorectal cancer. Therapy concepts encompassed topical or systemic curcumin administration. The studies reported heterogeneous results concerning oral and skin symptoms, pain, weight alteration and changes in body composition, survival, and disease progression. Significant findings were reported for oral mucositis and weight loss. Considering risk of bias, all studies had moderate to high risk of bias. Regarding side effects, one study reported significantly more vomiting in the curcumin group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although the results suggest promise in reducing mucositis and weight loss, a clear statement regarding the effectiveness of curcumin therapy on cancer patients cannot be made due to heterogeneous results and methodological limitations of the involved studies. Further investigations of higher quality are necessary to derive a definite recommendation for action.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00228-024-03764-9","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T13:02:12Z","timestamp":1729342932000},"page":"1-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Curcumin as a complementary treatment in oncological therapy: a systematic review"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6946-8410","authenticated-orcid":false,"given":"Lisa C.","family":"Gutsche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"D\u00f6rfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"3764_CR1","doi-asserted-by":"publisher","unstructured":"Bachmeier BE, Melchart D (2019) Therapeutic Effects of Curcumin-From Traditional Past to Present and Future Clinical Applications. Int J Mol Sci 20(15).https:\/\/doi.org\/10.3390\/ijms20153757","DOI":"10.3390\/ijms20153757"},{"key":"3764_CR2","doi-asserted-by":"publisher","first-page":"01021","DOI":"10.3389\/fphar.2020.01021","volume":"11","author":"J Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad J et al (2020) Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front Pharmacol 11:01021. https:\/\/doi.org\/10.3389\/fphar.2020.01021","journal-title":"Front Pharmacol"},{"key":"3764_CR3","doi-asserted-by":"publisher","unstructured":"Talib WH, et al (2020) Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation. Molecules (Basel, Switzerland) 25(22).https:\/\/doi.org\/10.3390\/molecules25225319","DOI":"10.3390\/molecules25225319"},{"key":"3764_CR4","doi-asserted-by":"publisher","unstructured":"Hassanzadeh K et al (2020) Obstacles against the Marketing of Curcumin as a Drug. Int J Mol Sci 21(18).https:\/\/doi.org\/10.3390\/ijms21186619","DOI":"10.3390\/ijms21186619"},{"issue":"2","key":"3764_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.47583\/ijpsrr.2021.v70i02.016","volume":"70","author":"R Ghosh","year":"2021","unstructured":"Ghosh R et al (2021) Curcumin: A systematic review. Int J Pharm Sci Rev Res 70(2):144\u2013148. https:\/\/doi.org\/10.47583\/ijpsrr.2021.v70i02.016","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"10","key":"3764_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/a-1207-9469","volume":"70","author":"R Ahsan","year":"2020","unstructured":"Ahsan R et al (2020) A Comprehensive Review on Physiological Effects of Curcumin. Drug Res 70(10):441\u2013447. https:\/\/doi.org\/10.1055\/a-1207-9469","journal-title":"Drug Res"},{"issue":"2","key":"3764_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1071\/HC15942","volume":"11","author":"N Martini","year":"2019","unstructured":"Martini N (2019) Turmeric. J Prim Health Care 11(2):187\u2013188. https:\/\/doi.org\/10.1071\/HC15942","journal-title":"J Prim Health Care"},{"key":"3764_CR8","unstructured":"Wissenschaftlichen, L.O.d.A.d., D.K.e.V.D. Medizinischen Fachgesellschaften e.V. (AWMF), and u.D.K. (DKH), Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Komplement\u00e4rmedizin in der Behandlung von onkologischen PatientInnen, Langversion 1.1. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/komplementaermedizin\/, 2021. AWMF Registernummer: 032\/055OL."},{"issue":"366","key":"3764_CR9","doi-asserted-by":"publisher","first-page":"I4898","DOI":"10.1136\/bmj.I4898","volume":"28","author":"JA Sterne","year":"2019","unstructured":"Sterne JA et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj 28(366):I4898. https:\/\/doi.org\/10.1136\/bmj.I4898","journal-title":"Bmj"},{"issue":"7","key":"3764_CR10","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.31557\/APJCP.2022.23.7.2333","volume":"23","author":"A Chaiworramukkul","year":"2022","unstructured":"Chaiworramukkul A et al (2022) A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Solid Cancer Patients. Asian Pac J Cancer Prev APJCP 23(7):2333\u20132340. https:\/\/doi.org\/10.31557\/APJCP.2022.23.7.2333","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"3","key":"3764_CR11","first-page":"147","volume":"10","author":"Charantimath,","year":"2016","unstructured":"Charantimath, (2016) Use of Curcumin in Radiochemotherapy Induced Oral Mucositis Patients: A Control Trial Study. Int J Med Health Sci 10(3):147\u2013152","journal-title":"Int J Med Health Sci"},{"key":"3764_CR12","doi-asserted-by":"publisher","unstructured":"Delavarian, Z., et al (2019) Oral administration of nanomicelle curcumin in the prevention of radiotherapy-induced mucositis in head and neck cancers. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 39(2): 166-172https:\/\/doi.org\/10.1111\/scd.12358","DOI":"10.1111\/scd.12358"},{"key":"3764_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.explore.2022.04.009","author":"F Fardad","year":"2022","unstructured":"Fardad F et al (2022) A comparative study to assess the effectiveness of curcumin, mucosamin, and chlorhexidine in chemotherapy-induced oral mucositis. Explore (New York, NY). https:\/\/doi.org\/10.1016\/j.explore.2022.04.009","journal-title":"Explore (New York, N.Y.)"},{"issue":"6","key":"3764_CR14","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.21037\/jgo-22-259","volume":"13","author":"JR Gunther","year":"2022","unstructured":"Gunther JR et al (2022) A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. J Gastrointestinal Oncol 13(6):2938\u20132950. https:\/\/doi.org\/10.21037\/jgo-22-259","journal-title":"J Gastrointestinal Oncol"},{"issue":"1","key":"3764_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/01635581.2016.1115527","volume":"68","author":"J Hejazi","year":"2016","unstructured":"Hejazi J et al (2016) Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: a Double Blinded, Randomized Placebo-Controlled Study. Nutr Cancer 68(1):77\u201385. https:\/\/doi.org\/10.1080\/01635581.2016.1115527","journal-title":"Nutr Cancer"},{"issue":"10","key":"3764_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4172\/1948-5956.1000222","volume":"5","author":"J Hejazi","year":"2013","unstructured":"Hejazi J et al (2013) A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer. J Cancer Sc Ther 5(10):320\u2013324. https:\/\/doi.org\/10.4172\/1948-5956.1000222","journal-title":"J Cancer Sc Ther"},{"issue":"7","key":"3764_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/jn\/nxz029","volume":"149","author":"LM Howells","year":"2019","unstructured":"Howells LM et al (2019) Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. J Nutr 149(7):1133\u20131139. https:\/\/doi.org\/10.1093\/jn\/nxz029","journal-title":"J Nutr"},{"issue":"1","key":"3764_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/IJTDH\/2016\/25780","volume":"16","author":"NB Kumar","year":"2016","unstructured":"Kumar NB, Kaur Paramjeet, Kumar DXJV, Khurana A, Chauhan A, A, (2016) Prospective Randomized Study Evaluating the Role of Oral Curcumin along with Chemoradiation in Management of Locally Advanced Head and Neck Carcinoma. Int J Tropical Disease Health 16(1):1\u20137","journal-title":"Int J Tropical Disease Health"},{"issue":"3","key":"3764_CR19","first-page":"269","volume":"13","author":"A Mansourian","year":"2015","unstructured":"Mansourian A et al (2015) The effect of \u201ccurcuma Longa\u201d topical gel on radiation -induced oral mucositis in patients with head and neck cancer. Int J Radiat Res 13(3):269\u2013274","journal-title":"Int J Radiat Res"},{"key":"3764_CR20","doi-asserted-by":"publisher","DOI":"10.30476\/mejc.2023.96676.1831","author":"N Najafizade","year":"2023","unstructured":"Najafizade N, Ebrahimi A, Hemati S (2023) A Randomized, Double-Blinded, Placebo-Controlled Study on the Protective Effects of Curcumin against Chemoradiotherapy-Induced Enteritis. Middle East J Cancer. https:\/\/doi.org\/10.30476\/mejc.2023.96676.1831","journal-title":"Middle East J Cancer"},{"issue":"1","key":"3764_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41405-021-00068-3","volume":"7","author":"R Nakao","year":"2021","unstructured":"Nakao R, Ueno T (2021) Effects of oral moisturizing gel containing propolis following head and neck radiotherapy: randomized controlled pilot trial. BDJ open 7(1):12. https:\/\/doi.org\/10.1038\/s41405-021-00068-3","journal-title":"BDJ open"},{"issue":"10","key":"3764_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/ptr.5149","volume":"28","author":"Y Panahi","year":"2014","unstructured":"Panahi Y et al (2014) Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. Phytotherapy Res PTR 28(10):1461\u20131467. https:\/\/doi.org\/10.1002\/ptr.5149","journal-title":"Phytotherapy Res PTR"},{"key":"3764_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-3-030-73234-9_17","volume":"1328","author":"Y Panahi","year":"2021","unstructured":"Panahi Y et al (2021) The Effects of Curcumin on the Side Effects of Anticancer Drugs in Chemotherapy: A Randomized Controlled Trial. Adv Exp Med Biol 1328:255\u2013273. https:\/\/doi.org\/10.1007\/978-3-030-73234-9_17","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"3764_CR24","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1002\/cam4.3806","volume":"10","author":"J Passildas-Jahanmohan","year":"2021","unstructured":"Passildas-Jahanmohan J et al (2021) Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer. Cancer Med 10(7):2332\u20132340. https:\/\/doi.org\/10.1002\/cam4.3806","journal-title":"Cancer Med"},{"issue":"8","key":"3764_CR25","doi-asserted-by":"publisher","first-page":"ZC59","DOI":"10.7860\/JCDR\/2015\/13034.6345","volume":"9","author":"K Patil","year":"2015","unstructured":"Patil K et al (2015) Use of Curcumin Mouthrinse in Radio-Chemotherapy Induced Oral Mucositis Patients: A Pilot Study. J Clinical Diagno Res JCDR 9(8):ZC59-62. https:\/\/doi.org\/10.7860\/JCDR\/2015\/13034.6345","journal-title":"J Clinical Diagno Res JCDR"},{"issue":"1","key":"3764_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12885-023-10730-8","volume":"23","author":"V Ramezani","year":"2023","unstructured":"Ramezani V et al (2023) Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial. BMC Cancer 23(1):354. https:\/\/doi.org\/10.1186\/s12885-023-10730-8","journal-title":"BMC Cancer"},{"issue":"1","key":"3764_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1667\/RR3255.1","volume":"180","author":"J Ryan","year":"2013","unstructured":"Ryan J et al (2013) Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 180(1):34\u201343. https:\/\/doi.org\/10.1667\/RR3255.1","journal-title":"Radiat Res"},{"issue":"3","key":"3764_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.22037\/uj.v0i0.5719","volume":"18","author":"S Sandoughdaran","year":"2021","unstructured":"Sandoughdaran S et al (2021) Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy. Urol J 18(3):295\u2013300. https:\/\/doi.org\/10.22037\/uj.v0i0.5719","journal-title":"Urol J"},{"issue":"2","key":"3764_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.22088\/cjim.13.2.9","volume":"13","author":"D Santosa","year":"2022","unstructured":"Santosa D et al (2022) Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial. Caspian J Intern Med 13(2):375\u2013384. https:\/\/doi.org\/10.22088\/cjim.13.2.9","journal-title":"Caspian J Intern Med"},{"issue":"5","key":"3764_CR30","doi-asserted-by":"publisher","first-page":"718","DOI":"10.4103\/ijdr.IJDR_822_18","volume":"31","author":"S Shah","year":"2020","unstructured":"Shah S et al (2020) Effectiveness of curcumin mouthwash on radiation-induced oral mucositis among head and neck cancer patients: A triple-blind, pilot randomised controlled trial. Indian J Dental Res Off Publ Indian Soc Dental Res 31(5):718\u2013727. https:\/\/doi.org\/10.4103\/ijdr.IJDR_822_18","journal-title":"Indian J Dental Res Off Publ Indian Soc Dental Res"},{"issue":"4","key":"3764_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/1874471015666220623104316","volume":"15","author":"T Talakesh","year":"2022","unstructured":"Talakesh T et al (2022) Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind Placebo-Controlled Trial. Curr Radiopharm 15(4):332\u2013340. https:\/\/doi.org\/10.2174\/1874471015666220623104316","journal-title":"Curr Radiopharm"},{"key":"3764_CR32","doi-asserted-by":"publisher","first-page":"5425619","DOI":"10.1155\/2022\/5425619","volume":"2022","author":"T Thambamroong","year":"2022","unstructured":"Thambamroong T et al (2022) Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia). J Nutr Metab 2022:5425619. https:\/\/doi.org\/10.1155\/2022\/5425619","journal-title":"J Nutr Metab"},{"key":"3764_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S0022215120000316","volume":"2","author":"P Arun","year":"2020","unstructured":"Arun P et al (2020) Role of turmeric extract in minimising mucositis in patients receiving radiotherapy for head and neck squamous cell cancer: a randomised, placebo-controlled trial. J Laryngol Otol 2:159\u2013164","journal-title":"J Laryngol Otol"},{"issue":"3","key":"3764_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1534735413503549","volume":"13","author":"S Rao","year":"2014","unstructured":"Rao S et al (2014) The Indian spice turmeric delays and mitigates radiation-induced oral mucositis in patients undergoing treatment for head and neck cancer: an investigational study. Integr Cancer Ther 13(3):201\u2013210. https:\/\/doi.org\/10.1177\/1534735413503549","journal-title":"Integr Cancer Ther"},{"issue":"7","key":"3764_CR35","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1007\/s00520-019-05166-5","volume":"28","author":"J Ryan Wolf","year":"2020","unstructured":"Ryan Wolf J et al (2020) Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial. Supportive Care Cancer\u202f: Off J Multinational Assoc Supportive Care Cancer 28(7):3303\u20133311. https:\/\/doi.org\/10.1007\/s00520-019-05166-5","journal-title":"Supportive Care Cancer : Off J Multinational Assoc Supportive Care Cancer"},{"issue":"1","key":"3764_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/NCC.0000000000001149","volume":"46","author":"PL Thomas","year":"2023","unstructured":"Thomas PL, Kang HK, Rishi KS (2023) Randomized Control Study of the Effects of Turmeric Mouthwash on Oral Health Status, Treatment-Induced Mucositis, and Associated Oral Dysfunctions Among Patients With Head and Neck Cancer. Cancer Nurs 46(1):36\u201344. https:\/\/doi.org\/10.1097\/NCC.0000000000001149","journal-title":"Cancer Nurs"},{"key":"3764_CR37","doi-asserted-by":"publisher","DOI":"10.1159\/000516577","author":"TP Soni","year":"2021","unstructured":"Soni TP et al (2021) A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis. ORL Head Neck Nurs. https:\/\/doi.org\/10.1159\/000516577","journal-title":"ORL Head Neck Nurs"},{"issue":"6","key":"3764_CR38","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pros.23766","volume":"79","author":"YH Choi","year":"2019","unstructured":"Choi YH et al (2019) A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation. Prostate 79(6):614\u2013621. https:\/\/doi.org\/10.1002\/pros.23766","journal-title":"Prostate"},{"key":"3764_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-73234-9_1","volume":"1328","author":"Y Panahi","year":"2021","unstructured":"Panahi Y et al (2021) Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial. Adv Exp Med Biol 1328:1\u20139. https:\/\/doi.org\/10.1007\/978-3-030-73234-9_1","journal-title":"Adv Exp Med Biol"},{"key":"3764_CR40","doi-asserted-by":"publisher","unstructured":"Ryan Wolf J et al (2017) Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients. Support Care Cancer 1\u201310. https:\/\/doi.org\/10.1007\/s00520-017-3957-4","DOI":"10.1007\/s00520-017-3957-4"},{"key":"3764_CR41","doi-asserted-by":"publisher","unstructured":"Saghatelyan, T., et al (2020) Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: a comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 70.https:\/\/doi.org\/10.1016\/j.phymed.2020.153218","DOI":"10.1016\/j.phymed.2020.153218"},{"key":"3764_CR42","doi-asserted-by":"publisher","unstructured":"Saadipoor A, et al (2018) Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy. Phytotherapy research : PTR, 2018. (no pagination).https:\/\/doi.org\/10.1002\/ptr.6230.","DOI":"10.1002\/ptr.6230"},{"issue":"1","key":"3764_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12906-021-03400-4","volume":"21","author":"SJ Kia","year":"2021","unstructured":"Kia SJ et al (2021) Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial. BMC Complement Med Ther 21(1):232. https:\/\/doi.org\/10.1186\/s12906-021-03400-4","journal-title":"BMC Complement Med Ther"},{"key":"3764_CR44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/pharmaceutics15041275","volume":"15","author":"C Waure","year":"2023","unstructured":"Waure C et al (2023) Exploring the Contribution of Curcumin to Cancer Therapy: A Systematic Review of Randomized Controlled Trials. Pharmaceutics 15:1275. https:\/\/doi.org\/10.3390\/pharmaceutics15041275","journal-title":"Pharmaceutics"},{"issue":"1","key":"3764_CR45","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-020-07256-8","volume":"20","author":"K Mansouri","year":"2020","unstructured":"Mansouri K et al (2020) Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer 20(1):791. https:\/\/doi.org\/10.1186\/s12885-020-07256-8","journal-title":"BMC Cancer"},{"key":"3764_CR46","doi-asserted-by":"publisher","unstructured":"Shafei L, MI Mohamed Ibrahim, Billa N (2021) Is Curcumin at the Threshold of Therapeutic Effectiveness on Patients with Colon Cancer?\u2014A Systematic Review. Front Pharmacol 12.https:\/\/doi.org\/10.3389\/fphar.2021.707231","DOI":"10.3389\/fphar.2021.707231"},{"key":"3764_CR47","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.31557\/APJCP.2021.22.6.1671","volume":"22","author":"S Dharman","year":"2021","unstructured":"Dharman S et al (2021) A Systematic Review and Meta-Analysis on the Efficacy of Curcumin\/Turmeric for the Prevention and Amelioration of Radiotherapy\/Radiochemotherapy Induced Oral Mucositis in Head and Neck Cancer Patients. Asian Pac J Cancer Prev 22:1671\u20131684. https:\/\/doi.org\/10.31557\/APJCP.2021.22.6.1671","journal-title":"Asian Pac J Cancer Prev"},{"key":"3764_CR48","doi-asserted-by":"publisher","unstructured":"Wu C-F et al (2024) Efficacy of turmeric in the treatment of oral mucositis in patients with head and neck cancer after radiotherapy or chemoradiotherapy: a systematic review and meta-analysis. Front Pharmacol 15.https:\/\/doi.org\/10.3389\/fphar.2024.1363202","DOI":"10.3389\/fphar.2024.1363202"},{"key":"3764_CR49","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/ptr.6326","volume":"33","author":"AG Normando","year":"2019","unstructured":"Normando AG et al (2019) Effects of turmeric and curcumin on oral mucositis: A systematic review. Phytother Res 33:1318\u20131329. https:\/\/doi.org\/10.1002\/ptr.6326","journal-title":"Phytother Res"},{"key":"3764_CR50","doi-asserted-by":"crossref","unstructured":"Dina Halegoua-DeMarzio, M., a Victor Navarro, MD,b Jawad Ahmad, MD,c Bharathi Avula, PhD,d, et al (2023) Liver Injury Associated with Turmeric\u2014A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]. Am J Med 136 200\u2212206","DOI":"10.1016\/j.amjmed.2022.09.026"},{"issue":"40","key":"3764_CR51","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3238\/arztebl.2019.0678","volume":"116","author":"D Kildal","year":"2019","unstructured":"Kildal D, Feldhaus FW, Gebauer B (2019) Port Occlusion Due to Curcumin Infusion. Deutsches Arzteblatt international 116(40):678. https:\/\/doi.org\/10.3238\/arztebl.2019.0678","journal-title":"Deutsches Arzteblatt international"},{"issue":"3","key":"3764_CR52","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bcp.14460","volume":"87","author":"N Lombardi","year":"2021","unstructured":"Lombardi N et al (2021) Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports. Br J Clin Pharmacol 87(3):741\u2013753. https:\/\/doi.org\/10.1111\/bcp.14460","journal-title":"Br J Clin Pharmacol"},{"key":"3764_CR53","doi-asserted-by":"publisher","unstructured":"Nadia Smati, M.C.X., MD1;Manasa Vallabhaneni, BSci2; and and M. Ibironke Oduyebo (2023) A Case of Turmeric-Induced Liver Injury. AIM Clinical Cases 2: e230090.https:\/\/doi.org\/10.7326\/aimcc.2023.0090.","DOI":"10.7326\/aimcc.2023.0090"},{"issue":"15","key":"3764_CR54","doi-asserted-by":"publisher","first-page":"20293","DOI":"10.18632\/oncotarget.7773","volume":"7","author":"HA Parsons","year":"2016","unstructured":"Parsons HA, Baracos VE, Hong DS, Abbruzzese J, Bruera E, Kurzrock R (2016) The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. Oncotarget 7(15):20293\u201320304","journal-title":"Oncotarget"},{"key":"3764_CR55","doi-asserted-by":"publisher","unstructured":"Servida, S., et al (2023) Overview of Curcumin and Piperine Effects on Glucose Metabolism: The Case of an Insulinoma Patient's Loss of Consciousness. Int J Mol Sci 24(7).https:\/\/doi.org\/10.3390\/ijms24076621.","DOI":"10.3390\/ijms24076621"},{"issue":"5","key":"3764_CR56","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4103\/ijdvl.IJDVL_9_19","volume":"86","author":"MY Wu","year":"2020","unstructured":"Wu MY, Y.H., Wang CW, Chung WH. (2020) Curcumin-induced acute generalized exanthematous pustulosis. Indian J Dermatol Venereol Leprol. 86(5):571\u20133","journal-title":"Indian J Dermatol Venereol Leprol."},{"issue":"2","key":"3764_CR57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/imj.14727","volume":"15","author":"S Chand","year":"2020","unstructured":"Chand S, Hai C, Beswick L (2020) A rare case of turmeric-induced hepatotoxicity. Intern Med J 15(2):258\u2013259. https:\/\/doi.org\/10.1111\/imj.14727","journal-title":"Intern Med J"},{"key":"3764_CR58","first-page":"849","volume":"14","author":"DA Aalam Sohal","year":"2021","unstructured":"Aalam Sohal DA (2021) Sunny Sandhu, JayaKrishna Chintanaboina, Turmeric-Induced Hepatotoxicity: Report of 2 Cases. Int Med Case Rep J 14:849\u2013852","journal-title":"Int Med Case Rep J"},{"issue":"11","key":"3764_CR59","first-page":"43","volume":"8","author":"SP Chaudhari","year":"2015","unstructured":"Chaudhari SP, Tam AY, Barr JA, Tan J (2015) Curcumin: A contact allergen. J Clin Aesthet Dermatol 8(11):43\u201348","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"3764_CR60","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/carcin\/bgp082","volume":"30","author":"ST Dance-Barnes","year":"2009","unstructured":"Dance-Barnes ST, Kock ND, Moore JE, Lin EY, Mosley LJ, D\u2019Agostino RB Jr, Miller MS (2009) Lung tumor promotion by curcumin. Carcinogenesis 30(6):1016\u20131023","journal-title":"Carcinogenesis"},{"key":"3764_CR61","unstructured":"Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit, Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Gemeinsame Expertenkommission zu Einstufung von Stoffen (2020) Stellungnahme zur Einstufung von Produkten, die Curcumin mit verbesserter Bioverf\u00fcgbarkeit enthalten. https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Zulassung\/ZulRelThemen\/abgrenzung\/Expertenkommission\/stellungnahmen\/2020-02.html"},{"key":"3764_CR62","doi-asserted-by":"publisher","unstructured":"Curcumin in Nahrungserg\u00e4nzungsmitteln: Gesundheitlich akzeptable t\u00e4gliche Aufnahmemenge kann \u00fcberschritten werden. Stellungnahme Nr. 040\/2021 des BfR vom 14. Dezember 2021, 2021.https:\/\/doi.org\/10.17590\/20211214-121912.","DOI":"10.17590\/20211214-121912"},{"key":"3764_CR63","doi-asserted-by":"publisher","first-page":"478","DOI":"10.14694\/EdBook_AM.2014.34.e478","volume":"34","author":"P Michelle Harvie","year":"2014","unstructured":"Michelle Harvie P (2014) SRD, Nutritional Supplements and Cancer: Potential Benefits and Proven Harms. Am Soc Clin Oncol Educ Book 34:478\u2013486","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"3764_CR64","doi-asserted-by":"crossref","unstructured":"Christine B. Ambrosone, G.R.Z., Alan D. Hutson, William E. McCann, Susan E. McCann, William E. Barlow, Kara M. Kelly, Rikki Cannioto, Lara E. Sucheston-Campbell, Dawn L. Hershman, Joseph M. Unger, Halle C.F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobagyi, Julie R. Gralow, George T. Budd, Kathy S. Albain (2019) Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221). J Clin Oncol 38: 804-814","DOI":"10.1200\/JCO.19.01203"},{"key":"3764_CR65","doi-asserted-by":"crossref","unstructured":"Audrey Y Jung, X.C., Kathrin Thoene, Nadia Obi, Stefanie Jaskulski, Sabine Behrens, Dieter Flesch-Janys, and Jenny Chang-Claude (2019) Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy. Am J Clin Nutr 109 69\u201378","DOI":"10.1093\/ajcn\/nqy223"},{"key":"3764_CR66","doi-asserted-by":"publisher","unstructured":"Page MJ, M.J., Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. . BMJ 372(71).https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03764-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T07:14:07Z","timestamp":1735802047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03764-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3764"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03764-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}